Tag: genomics
-
Crispr Enables Inhaled Flu, Covid-19 Treatment
A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device.
-
Small Biz Grant Funds Hibernating Animal Drug Discovery
A company identifying drug targets from genetic processes in hibernating animals is receiving an NIH grant to advance its technology for heart disease.
-
Gene-Edited Transplant Organ Company Raises $125M
A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for human transplantation.
-
Diagnostic Cleared for Covid-19, Other Diseases
A single diagnostic test for the virus causing Covid-19 infections and three other respiratory diseases received clearance for marketing in Europe.
-
Gene-Editing Biotech Acquires DNA Bar Code Company
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes.
-
FDA Issues Covid-19 Variant Regulatory Guidance
Food and Drug Administration is updating its regulatory guidance for Covid-19 drugs and diagnostics to cover emerging mutations in the SARS-CoV-2 virus.
-
Crispr-Edited Bananas Get Industry Funding
A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand.
-
Novartis, Gates Partner on Sickle Cell Gene Therapy
Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease.
-
20 Precision Meds Approved by FDA in 2020
A report by a group advocating for precision medicine notes that the Food and Drug Administration approved 20 new personalized drugs and biologics in 2020.
-
AI Designs Better Gene Therapy Delivery Viruses
An academic-industry team used machine learning to design more effective variations of common benign viruses that deliver gene therapies.